ACEROLA
Food supplement declared in France
ACEROLA (MAJELIS) is a food supplement declared in France. Status: retrait du marché annoncé pour le 30 November 2028. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- MAJELIS
- Food business operator placing the product on the market
- SAS MAJELIS
- Status
- Retrait du marché annoncé pour le 30 November 2028
- Form
- Gélule
- Daily dose
- 2 gélules
- Directions for use
- 1 à 2 gélules par jour
- Intended populations
- Population générale
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Femmes enceintes, Enfants (de moins de 10 ans)
- Objectives stated by the manufacturer (these are not authorised claims)
- Autre : Tonus
Declaration 347507, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 30 November 2028, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Malpighia glabra L. | Baie | Autre extrait sec | 1,000 mg |
Additives
E300, E464
Other ingredients
maltodextrine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Les femmes enceintes ou allaitantes sont invitées à prendre l'attache d'un professionnel de santé avant toute complémentation.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.
Brand : MAJELIS